Schedule 13G ownership disclosure

Diffusion Pharmaceuticals Inc.

Security class unavailable · CUSIP: 253748107

Event date: 2015-04-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-459467
Form type
SC 13G/A
Filer
CervoMed Inc.
CIK
CIK 1053691
Filed
Feb 11, 2016
Reporting period
Apr 01, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub